SPAIN LAUNCHES LARGE-SCALE STUDY OF HYDROXYCHLOROQUINE AND ANTIRETROVIRALS TO PREVENT COVID-19 IN HEALTH WORKERS

newsweek.com ^ | 4/10/20 | LYDIA SMITH

[rintintin]

he Spanish government has announced it will be launching a clinical trial into whether hydroxychloroquine and certain antiretrovirals can prevent frontline health workers from contracting COVID-19.

The research, dubbed the Clinical Trial for the Prevention of Coronavirus Infection in Health Workers (EPICOS) will study 4,000 health workers, from wardens to doctors, at 62 hospitals in 13 regions in Spain.

The EPICOS investigation will evaluate to what extent existing medicines may offer protection against coronavirus.

One group of participants will be given the anti-malaria drug hydroxychloroquine, while another will take a combination of the antiretroviral medications emtricitabine and tenofovir, a medication currently used to treat and prevent HIV. A third group will be given a placebo.

Ads by scrollerads.com The randomized double-blind clinical trial, which will be overseen by the Spanish Medicines Agency, will release its first results in four weeks' time.

[Steve Van Doorn]

Prevention of Coronavirus Infection in Health Workers (EPICOS) sounds brand new which suggest deception. Gates maybe?

[Steve Van Doorn]

There’s a number of doctors that prescribe HCQ which is only after the HCQ neutralizes the Viroprotein while ignoring the Zinc Ionophere properties. Which Vitamin-C is critical

[Chauncey Gardiner]

Let’s send the DNC to take the placebo

[Hiddigeigei]

I assume that all taking part will be checked frequently for the virus and those showing infection will be treated immediately with the Hydroxychoroquine-azithromycin-zinc cocktail if not taking it already.

[dp0622]

Now THAT makes sense.

But doesn’t that inherently taint the study?

How much the virus progresses and how bad it affects each group would be, I think, important aspects of the study.

Treating those who show infection will taint those results very much, no?

[Hiddigeigei]

Treating those who show infection will taint those results very much, no?
It depends on whether the study is designed to see if the treatment protects against infection or severity of illness after infection. If the subject is young and healthy, there's a good chance he/she isn't going to show severe symptoms anyway.

[marron]

They are a little late to the dance.

[Basket_of_Deplorables]

Good for Spain 1st responders, but not for us???

https://petitions.whitehouse.gov/petition/allow-us-individuals-use-hydroxychloroquine-preventative-covid-19-open-country-and-go-back-work

[dp0622]

Yeah that’s true.

I would hope they’d treat them.

I’ve read of studies with placebos where it was rally life and death and there was NO other treatment in the end stages.

Usually cancer drug tests.

I guess in that case some brave souls know there’s very little chance anyway and they do it to help others in the future.

This is a different situation, as you’ve pointed out.